Immunosuppressive drugs: the first 50 years and a glance forward.

@article{Allison2000ImmunosuppressiveDT,
  title={Immunosuppressive drugs: the first 50 years and a glance forward.},
  author={Anthony C. Allison},
  journal={Immunopharmacology},
  year={2000},
  volume={47 2-3},
  pages={
          63-83
        }
}
  • A. Allison
  • Published 1 May 2000
  • Biology, Medicine
  • Immunopharmacology
During the past 50 years, many immunosuppressive drugs have been described. Often their mechanisms of action were established long after their discovery. Eventually these mechanisms were found to fall into five groups: (i) regulators of gene expression; (ii) alkylating agents; (iii) inhibitors of de novo purine synthesis; (iv) inhibitors of de novo pyrimidine synthesis; and (v) inhibitors of kinases and phosphatases. Glucocorticoids exert immunosuppressive and anti-inflammatory activity mainly… Expand
From Leflunomide to Teriflunomide: Drug Development and Immuno-suppressive Oral Drugs in the Treatment of Multiple Sclerosis
TLDR
Teriflunomide has shown a favorable safety and efficacy profile in RRMS and is a therapeutic option for a distinct group of adult patients with RRMS. Expand
Impact of Immunosuppressive Drugs on the Metabolism of T Cells.
TLDR
This review highlights emerging concepts about the modulation of metabolic reprogramming in T-cell responses by immunosuppressive drugs and how potential therapeutic interventions influence T- cell fate and effector function. Expand
Immunosuppressives in transplant rejection
TLDR
Progress in this area has not only resulted in improved IMMUNOSUPPRESSION, but also in potential approaches to induce a status of unresponsiveness, i.e., TOLERANCE to the transplant. Expand
[Effect of methotrexate on the immune response in selected experimental models].
TLDR
Methotrexate has been an effective agent in suppressing immunological disorders (for 50 years) and is still finding many applications. Expand
Mycophenolate mofetil and its mechanisms of action.
TLDR
The efficacy of regimes including CellCept(R) in preventing allograft rejection, and in the treatment of rejection, is now firmly established and it is hoped that the drug will have the same effect in humans. Expand
Restriction of De Novo Nucleotide Biosynthesis Interferes with Clonal Expansion and Differentiation into Effector and Memory CD8 T Cells12
TLDR
The results show that methotrexate and 5-fluorouracil prevent the acquisition of effector functions, such as IFN-γ, granzyme B expression, and cytotoxic function following antigenic stimulation of naive cells, and the drugs are unable to inhibit the development of improved cytot toxic functions displayed by memory CD8 T cells. Expand
Guanine nucleotide depletion triggers cell cycle arrest and apoptosis in human neuroblastoma cell lines
TLDR
Results suggest that in neuroblastoma cell lines clinically attainable concentrations of mycophenolic acid deplete guanine nucleotide pools triggering G1 arrest and apoptosis through p53‐mediated pathways, indicating a potential role of its morpholinoethyl ester pro‐drug in the management of patients with neuroectodermal tumors. Expand
Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases.
TLDR
Bisbenzylisoquinoline alkaloids can regulate several signaling pathways in abnormally activated T cells with low toxicity and deserve to be paid more attention as a lead compound to develop new drugs for the treatment of T cell-involved diseases in the future. Expand
Mechanisms of action of mycophenolate mofetil
TLDR
Evidence is accumulating that MMF may have clinical utility in some autoimmune disorders, and it is suggested that it reduces acute and chronic rejection in allograft recipients and is efficacious in some nephropathies. Expand
Design, synthesis, and evaluation of quinazoline T cell proliferation inhibitors.
TLDR
A new class of quinazoline molecules that inhibit T cell proliferation may serve as lead molecules for the development of agents aimed at diseases in which T cell signaling plays a role and agents to induce tolerance to grafted tissues or organs. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 128 REFERENCES
Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases.
TLDR
A summary of current in vivo and in vitro data, focussing primarily on the mechanism of action of leflunomide in RA, suggests that the pyrimidine sugars necessary for protein glycosylation support the massive expansion in membrane biosynthesis to form daughter cells. Expand
Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells.
TLDR
The data demonstrate that MTX can selectively delete activated peripheral blood T cells by a CD95-independent pathway, and this property could be used as a new pharmacological end point to optimize dosage and timing of MTX administration. Expand
The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis.
TLDR
The results support the hypothesis that the in vitro effects of leflunomide on T-lymphocytes are due to inhibition of de novo pyrimidine synthesis, and inhibition of dihydroorotate dehydrogenase. Expand
Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
TLDR
It is concluded that mizoribine selectively inhibits guanine ribonucleotide formation in purified T cells, whereas the effect of 6MP appears to be more dependent on adenine rib onucleotide depletion. Expand
Mycophenolate mofetil and its mechanisms of action.
TLDR
The efficacy of regimes including CellCept(R) in preventing allograft rejection, and in the treatment of rejection, is now firmly established and it is hoped that the drug will have the same effect in humans. Expand
Antipurines and Purine Metabolism
The study of the involvement of purines in lymphocyte function has been highlighted by two dramatic and unrelated discoveries. The first, the discovery in 1958 that 6-mercaptopurine (6-MP) had markedExpand
Biological effects of cyclosporin A: A new antilymphocytic agent
TLDR
Experimental evidence suggests that cyclosporin A affects an early stage of mitogenic triggering of the immunocompetent lymphoid cell, which contrasts with other immunosuppressives and cytostatic drugs in its weak myelotoxicity. Expand
Immunopharmacological profile of HWA 486, a novel isoxazol derivative--II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin A.
  • R. Bartlett
  • Chemistry, Medicine
  • International journal of immunopharmacology
  • 1986
We have shown in earlier studies that the isoxazol derivative, HWA 486, prevents the onset of the adjuvant disease in Lewis rats. The diminished arthritic reaction was correlated with an improvedExpand
Immunopharmacology of rapamycin.
TLDR
Accumulating data suggest that mTOR functions in a previously unrecognized signal transduction pathway required for the progression of IL-2-stimulated T cells from G1 into the S phase of the cell cycle. Expand
THE EFFECT OF A NEW IMMUNOSUPPRESSIVE DRUG, BREQUINAR SODIUM, ON HEART, LIVER, AND KIDNEY ALLOGRAFT REJECTION IN THE RAT
TLDR
The immunosuppressive activity of BQR is highly effective in prolonging heart, liver, and kidney allograft survival in the rat and should be an important addition to a polytherapeutic approach in the treatment of organ graft rejection. Expand
...
1
2
3
4
5
...